Difficulty: Medium
Average Score: 84%
Practice
Which of the following nursing diagnoses would provide the most plausible indication for the use of epoetin alfa (Epogen) in a patient with renal failure?
Correct answer
B
Rationale
In a patient with renal failure, the correct nursing diagnosis that would provide the most plausible indication for the use of epoetin alfa (Epogen) is "B) Activity intolerance related to decreased oxygen-carrying capacity."
Epoetin alfa is a synthetic form of erythropoietin, a hormone produced by the kidneys that stimulates red blood cell production in bone marrow. In renal failure, the kidneys are unable to produce enough erythropoietin, leading to decreased red blood cell production and subsequently decreased oxygen-carrying capacity in the blood. By administering epoetin alfa, we can stimulate red blood cell production and improve oxygen delivery to tissues, thus alleviating activity intolerance caused by tissue hypoxia.
Regarding the other options:
A) Risk for infection related to decreased erythropoiesis - While decreased red blood cell count can contribute to impaired immune function, epoetin alfa is not used to directly address infection risk.
C) Powerlessness-related sequelae of renal failure - This is more related to psychological and emotional aspects of care and not directly linked to the physiological effects of epoetin alfa.
D) Ineffective breathing pattern related to inadequate erythropoietin synthesis - While inadequate erythropoietin synthesis can lead to anemia and tissue hypoxia, the use of epoetin alfa would address the oxygen-carrying capacity concern rather than directly impacting breathing patterns.
Understanding the rationale behind selecting the correct nursing diagnosis in this context is crucial for nurses to provide optimal care for patients with renal failure and associated anemia. By linking the pathophysiology of renal failure to the therapeutic action of epoetin alfa, nurses can make informed clinical decisions and improve patient outcomes.
Epoetin alfa is a synthetic form of erythropoietin, a hormone produced by the kidneys that stimulates red blood cell production in bone marrow. In renal failure, the kidneys are unable to produce enough erythropoietin, leading to decreased red blood cell production and subsequently decreased oxygen-carrying capacity in the blood. By administering epoetin alfa, we can stimulate red blood cell production and improve oxygen delivery to tissues, thus alleviating activity intolerance caused by tissue hypoxia.
Regarding the other options:
A) Risk for infection related to decreased erythropoiesis - While decreased red blood cell count can contribute to impaired immune function, epoetin alfa is not used to directly address infection risk.
C) Powerlessness-related sequelae of renal failure - This is more related to psychological and emotional aspects of care and not directly linked to the physiological effects of epoetin alfa.
D) Ineffective breathing pattern related to inadequate erythropoietin synthesis - While inadequate erythropoietin synthesis can lead to anemia and tissue hypoxia, the use of epoetin alfa would address the oxygen-carrying capacity concern rather than directly impacting breathing patterns.
Understanding the rationale behind selecting the correct nursing diagnosis in this context is crucial for nurses to provide optimal care for patients with renal failure and associated anemia. By linking the pathophysiology of renal failure to the therapeutic action of epoetin alfa, nurses can make informed clinical decisions and improve patient outcomes.